Powerful investment in GASPOROX subsidiary GPX Medical, the Board recruits Hanna Sjöström as new CEO from January 28, 2019

Publicerat den 22 January, 2019
Gasporox subsidiary GPX Medical recruits a new CEO to work with GPX Medicals developing- and commercialization phase.

Hanna Sjöström worked most recently at TePe Munhygienprodukter AB where she, in her role as marketing director, worked with product development, marketing and sales as well as business development. Hanna Sjöström, with a Master of Science in Business and Economics, Technology Management Major, from Lund University, has long international commercial and development experience.

"Hanna brings her experience from growth companies in the dental industry, together with her international background from leading roles in large companies like The Coca-Cola Company and L'Oréal, to be able to take over the leadership of GPX Medical in its developing- and commercialization phase," says Märta Lewander Xu, CEO at Gasporox.

“It feels exciting to be able to lead such a technically knowledgeable team with my commercial background and to establish, among other things, the laser-based method for gas monitoring in the lungs of premature babies in the market. The method can be of significant use for the healthcare industry and has a strong market potential, we expect strong international growth for the company when the method reaches success in its commercial phase.”, says Hanna Sjöström.

For more information about Gasporox subsidiary GPX Medical, visit: http://www.gasporox.se/about/gpx-medical/ 

For further information, please contact:

Märta Lewander Xu, CEO, tel: +46 702-95 11 13, e-mail: ml@gasporox.se 

____________________________________________________________________________

GASPOROX in short

Gasporox offers inspection- and quality systems for packaging with a protective atmosphere. The company supplies the life and pharmaceutical industry with laser sensors for quality control of the gas in which the product is packaged and which prolongs its durability. Unlike existing methods, Gasporox's unique technology can cater to the packaging industry's need for automated, complete and cost-effective quality control. The number of packaging with protective atmosphere is estimated at 200 billion annually in the food industry. Gasporox also, through its partly owned subsidiary GPX Medical AB, develops laser technology for medical diagnostics. More information about the business is available at www.gasporox.se. The Companys Certified Adviser is FNCA Sweden AB, +46(0)8-528 00 399, info@fnca.se.